Essential Tremor
📧 Sign up to get email alerts when something new happens for Essential Tremor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor [NA]
A clinical trial evaluating the safety and efficacy of staged bilateral MR-guided focused ultrasound thalamotomy for essential tremor is ong…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Directional Bilateral Thalamic Patterned Stimulation (Chronos) [NA]
A clinical trial evaluating directional bilateral thalamic patterned stimulation (Chronos) for essential tremor is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Electroclinical Correlates in Essential Tremor [NA]
This clinical trial update indicates that a study on electroclinical correlates in essential tremor is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Deep Brain Stimulation Effects in Essential Tremor
A completed clinical trial evaluating the effects of deep brain stimulation on essential tremor symptoms.
-
CLINICAL_TRIALS withdrawal · 2024-09-25Clinical Trial Update: Acamprosate and Methazolamide for Essential Tremor [Phase 2]
A Phase 2 clinical trial evaluating acamprosate and methazolamide for essential tremor was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: 24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]
This update describes an ongoing clinical trial evaluating the safety and efficacy of Peroneal Transcutaneous NeuroModulation in Parkinson's…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]
Completed clinical trial evaluating safety and efficacy of peroneal transcutaneous neuro modulation in Parkinson's disease and essential tre…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor
Post-market clinical follow-up study of the directSTIM Deep Brain Stimulation System for essential tremor has been terminated.
-
FDA approval · 2024-07-11FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for propranolol hydrochloride by Lannett Company, Inc., approving changes to the existing ANDA to su…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors [NA]
Clinical trial update on ExAblate Transcranial MR-guided focused ultrasound for essential tremor; the continued access protocol has complete…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor [NA]
Pilot trial update for the Felix System in essential tremor and Parkinson disease; the study has completed.
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery
This ongoing clinical study uses microelectrode recording during deep brain stimulation surgery to measure sensory gating and explore neural…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Bilateral Essential Tremor Treatment With FUS [NA]
This update notes that a bilateral focused ultrasound treatment trial for essential tremor is currently active but not recruiting, sponsored…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Retrospective Study on MR Imaging of ET and PD Patients Subjected With MRgFUS Thalamotomy
A retrospective study evaluating MRI findings in essential tremor and Parkinson's disease patients after MR-guided focused ultrasound thalam…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: A Second Magnetic Resonance Guided Focused Ultrasound Thalamotomy for Essential Tremor [NA]
This clinical trial update reports the completion of a second MRI-guided focused ultrasound thalamotomy trial for essential tremor.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor [Phase 2]
Phase 2 trial evaluating SAGE-324 for essential tremor has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors [NA]
This Clinical Trials update reports the completion of a study evaluating ExAblate Transcranial MR Guided Focused Ultrasound for essential tr…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor [Phase 2]
Phase 2 clinical trial evaluating two doses of PRAX-944 in participants with essential tremor has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Clinical Trial of PRAX-944 in Participants With Essential Tremor [Phase 2]
Phase 2 trial update for PRAX-944 in essential tremor has been completed with results posted.
-
FDA approval · 2023-11-07FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc. The action confirms regulato…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Prospective Study for Symptomatic Relief of ET With Cala Therapy [NA]
Prospective study completed evaluating Cala Therapy for symptomatic relief in essential tremor; results posted in 2023.
-
FDA approval · 2023-09-12FDA Approved: IOFLUPANE I 123 — Supplemental Application (Curium US LLC)
FDA approved a supplemental application for IOFLUPANE I-123 (DaTSCAN) from Curium US LLC.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Cala ONE Device for Essential Tremor [NA]
Clinical trial update for the Cala ONE device in essential tremor; study completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Atlas Predicted DBS Settings in Essential Tremor [NA]
Clinical trial update indicates termination of a study evaluating atlas-predicted deep brain stimulation settings for essential tremor, with…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors [Phase 2]
Phase 2 clinical trial update evaluating efficacy, safety, and pharmacokinetics of ES-481 in adults with essential tremor.